A groundbreaking study reveals that depleting the gut microbiome in aged mice improves memory and reduces brain inflammation, highlighting the gut-brain axis as a target for non-invasive aging interve...
Recent research confirms TDP-43 aggregation in vascular dementia, with advancements in biomarkers and therapies highlighting potential for early intervention and personalized prevention. New studies r...
A July 2024 study in ‘Nature Aging’ validates p-tau217 blood biomarkers for forecasting Alzheimer’s symptoms within 3-4 years, enhancing early intervention and personalized medicine....
Recent advances in partial cellular reprogramming using OSKM factors show promise in extending healthspan and treating age-related diseases, with biotech firms accelerating towards human trials. New r...
Recent research shows targeted removal of dysfunctional B cells in aged mice improves immune function and healthspan, suggesting new therapeutic avenues for combating age-related decline. A new study ...
Partial OSK reprogramming rejuvenates engram neurons in aged mice, improving memory by over 50%, with recent studies enhancing safety and biotech firms advancing towards human trials. New research sho...
Gut Microbiome Alterations Linked to Early Alzheimer’s Risk, Revealing New Pathways for Intervention
Recent studies connect gut microbiome changes to mild cognitive impairment, highlighting the microbiota-gut-brain axis’s role in early Alzheimer’s detection and potential probiotic-based t...
Recent research reveals ferroptosis, an iron-dependent cell death mechanism, as a key factor in age-related muscle loss, with potential therapies targeting lipid peroxidation. A 2023 study in ‘A...
In 2025, aging research sees major advancements with senolytics and mitochondrial therapies, backed by clinical trials and shifting medical attitudes towards treating aging as a condition. Recent tria...
Recent animal studies show senolytic vaccines reduce tumor growth by up to 50% when combined with anti-PD-L1, with clinical trials advancing for lung cancer and melanoma. Emerging senolytic vaccines t...
